{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:58:01Z","timestamp":1740128281785,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s13365-021-00980-2","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T18:14:52Z","timestamp":1618856092000},"page":"510-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3186-1562","authenticated-orcid":false,"given":"S.","family":"Borrelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dachy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-D.","family":"Gazagnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Du Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"20","key":"980_CR1","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A et al (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366(20):1870\u20131880","journal-title":"N Engl J Med"},{"key":"980_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.npbr.2020.05.008","volume":"37","author":"AO Correia","year":"2020","unstructured":"Correia AO, Feitosa PWG, Moreira JLS, Nogueira SAR, Fonseca RB, Nobre MEP (2020) Neurological manifestations of COVID-19 and other coronaviruses: as systematic review. Neurol Psychiatry Brain Res 37:27\u201332","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"Suppl 1","key":"980_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/13550280390195315","volume":"9","author":"RA Du Pasquier","year":"2003","unstructured":"Du Pasquier RA, Koralnik IJ (2003) Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 9(Suppl 1):25\u201331","journal-title":"J Neurovirol"},{"issue":"Pt 9","key":"980_CR4","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/brain\/awh215","volume":"127","author":"RA Du Pasquier","year":"2004","unstructured":"Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ (2004) A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127(Pt 9):1970\u20131978","journal-title":"Brain"},{"issue":"3","key":"980_CR5","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1148\/radiol.2015150673","volume":"278","author":"J Hodel","year":"2016","unstructured":"Hodel J, Outteryck O, Dubron C, Dutouquet B, Benadjaoud MA, Duhin E et al (2016) Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab: diagnostic precision with MR imaging. Radiology 278(3):863\u2013872","journal-title":"Radiology"},{"key":"980_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fneur.2020.00715","volume":"11","author":"M Khateb","year":"2020","unstructured":"Khateb M, Bosak N, Muqary M (2020) Coronaviruses and central nervous system manifestations. Front Neurol 11:715","journal-title":"Front Neurol"},{"issue":"9","key":"980_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354(9):899\u2013910","journal-title":"N Engl J Med"},{"issue":"9","key":"980_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"RA Rudick","year":"2006","unstructured":"Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW et al (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354(9):911\u2013923","journal-title":"N Engl J Med"},{"key":"980_CR9","doi-asserted-by":"publisher","first-page":"100094","DOI":"10.1016\/j.bbih.2020.100094","volume":"5","author":"P Scoppettuolo","year":"2020","unstructured":"Scoppettuolo P, Borrelli S, Naeije G (2020) Neurological involvement in SARS-CoV-2 infection: a clinical systematic review. Brain BehavImmun Health 5:100094","journal-title":"Brain BehavImmun Health"},{"issue":"1","key":"980_CR10","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"JW Song","year":"2020","unstructured":"Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P et al (2020) Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun 11(1):3410","journal-title":"Nat Commun"},{"issue":"11","key":"980_CR11","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","volume":"77","author":"IL Tan","year":"2011","unstructured":"Tan IL, McArthur JC, Clifford DB, Major EO, Nath A (2011) Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77(11):1061\u20131067","journal-title":"Neurology"},{"key":"980_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijid.2021.01.002","volume":"104","author":"M Tandon","year":"2021","unstructured":"Tandon M, Kataria S, Patel J, Mehta TR, Daimee M, Patel V et al (2021) A comprehensive systematic review of CSF analysis that defines neurological manifestations of COVID-19. Int J Infect Dis 104:390\u2013397","journal-title":"Int J Infect Dis"},{"issue":"8","key":"980_CR13","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","volume":"267","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Kang H, Li S, Zhao X (2020) Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 267(8):2179\u20132184","journal-title":"J Neurol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-021-00980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-021-00980-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-021-00980-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T14:46:02Z","timestamp":1625150762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-021-00980-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1007\/s13365-021-00980-2","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}